Immuron IMRN
NASDAQ IMRN
$1.25 +0.01 (+1.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Immuron (IMRN) Retained Earnings (2016 - 2026)

Immuron (IMRN) posted Retained Earnings of -$85.1 million for Q3 2026, down 3.26% on a QoQ basis from -$82.4 million in Q4 2025, and down 10221.1% year-over-year from N/an in Q3 2025.

Analysis

Immuron (IMRN) Retained Earnings (2016 - 2026) Analysis & Trends

Immuron has reported Retained Earnings for 11 years, with the latest figure at -$85.1 million in Q3 2026.

  • On a quarterly basis, Retained Earnings fell 10221.1% year-over-year to -$85.1 million in Q3 2026; TTM through Aug 2026 was -$85.1 million, a 10221.1% decrease from a year earlier, with the FY2026 full-year figure at -$85.1 million, down 10221.1% from the prior year.
  • Retained Earnings was -$85.1 million for Q3 2026 at Immuron, down from -$82.4 million in the prior quarter.
  • The five-year high for Retained Earnings was -$526194.1 in Q3 2024, with the low at -$85.1 million in Q3 2026.
  • Average Retained Earnings over 5 years is -$43.6 million, with a median of -$47.9 million recorded in 2023.
  • The sharpest annual moves came in 2023 and 2026: Retained Earnings soared 98.49% in 2023, then plunged 10221.1% in 2026.
  • Over 5 years, Retained Earnings stood at -$45.0 million in 2022, then dropped by 4.34% to -$46.9 million in 2023, then dropped by 10.09% to -$51.6 million in 2024, then tumbled by 59.64% to -$82.4 million in 2025, then fell by 3.26% to -$85.1 million in 2026.
  • The last three Retained Earnings figures came in at -$85.1 million (Q3 2026), -$82.4 million (Q4 2025), and -$824804.3 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 212.54 Bn 198.55 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 186.84 Bn 183.58 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 129.39 Bn 121.54 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 82.05 Bn 74.06 Bn 3.93 Bn 37.62 Bn
5 Moderna 69.00 Bn 63.87 Bn 52.00 Mn 5.10 Bn
6 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn 558.00 Mn
7 Alnylam Pharmaceuticals 32.67 Bn 29.37 Bn 992.69 Mn -6.33 Bn
8 Biogen 32.37 Bn 31.08 Bn 1.96 Bn 20.97 Bn
9 Roivant Sciences 28.18 Bn 28.87 Bn 1.16 Mn 5.13 Bn
10 Immuron 7.25 Mn -1.77 Mn - -85.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Aug 28, 2026 -85.13 Mn
Dec 31, 2025 -82.44 Mn
Sep 2, 2025 -824,804.27
Jun 30, 2025 -52.80 Mn
Dec 31, 2024 -51.64 Mn
Sep 9, 2024 -526,194.07
Jun 30, 2024 -52.04 Mn
Dec 31, 2023 -46.91 Mn
Sep 28, 2023 -47.23 Mn
Aug 30, 2023 -720,553.96
Jun 30, 2023 -48.16 Mn
Dec 31, 2022 -44.96 Mn
Aug 31, 2022 -47.58 Mn
Jun 30, 2022 -49.01 Mn
Dec 31, 2021 -48.26 Mn
Sep 30, 2021 -48.48 Mn
Jun 30, 2021 -50.77 Mn
Dec 31, 2020 -42.33 Mn
Sep 1, 2020 -57.92 Mn
Jun 30, 2020 -37.96 Mn
API Access

Immuron Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=IMRN&period=max&api_key=YOUR_API_KEY